Investors in Canopy Growth Corporation (CGC): Protect Your Rights – Contact Levi & Korsinsky Before June 3, 2025

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/canopy-growth-corporation-lawsuit-submission-form?prid=150347&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

African Energy Chamber: Angolan President João Lourenco Selected as ‘Energy Person of the Year’

President Lourenço has transformed Angola’s oil and gas sector through regulatory reform, peace and stability, good governance and anti-corruption JOHANNESBURG, SOUTH AFRICA / ACCESS Newswire / May 27, 2025 / Angola’s President João Lourenço has been selected as the ‘Energy Person of the Year’ by the African Energy Chamber (AEC) ( www.EnergyChamber.org ), in recognition

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Direct Digital Holdings Inc. (DRCT) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Direct Digital Holdings Inc. ("Direct Digital" or "the Company") (NASDAQ:DRCT). Investors who purchased Direct Digital securities prior to April 17, 2023, and continue to hold to the present, are

Bronstein, Gewirtz & Grossman, LLC Is Investigating Methode Electronics, Inc. (MEI) And Encourages Investors to Connect

NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Methode Electronics, Inc. ("Methode Electronics" or "the Company") (NYSE:MEI). Investors who purchased Methode Electronics securities prior to December 2, 2021, and continue to hold to the present, are encouraged

ATNM DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important May 27 Deadline in Securities Class Action – ATNM

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Rosen Law Firm: WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) between October 31, 2022 and August 2, 2024, both dates inclusive (the "Class Period"), of the important May 27, 2025 lead

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA). Investors who purchased Paragon 28 securities prior to May 5, 2023, and continue to hold to the present, are encouraged

Grocery Outlet Holding Corp. (GO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Grocery Outlet Holding Corp. ("Grocery Outlet" or "the Company") (NASDAQ:GO). Investors who purchased Grocery Outlet securities prior to April 9, 2023, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Extreme Networks, Inc. (EXTR) and Encourages Investors to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Extreme Networks, Inc. ("Extreme Networks" or "the Company") (NASDAQ:EXTR). Investors who purchased Extreme Networks securities prior to July 27, 2022, and continue to hold to the present, are encouraged to

Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amylyx Pharmaceuticals, Inc. ("Amylyx" or "the Company") (NASDAQ:AMLX). Investors who purchased Amylyx securities prior to November 11, 2022, and continue to hold to the present, are encouraged to obtain

Scroll to Top